Scopus BioPharma Inc. (SCPS)
Chart Events
Performance Outlook
| Previous Close | 9.20 |
| Open | 10.00 |
| Bid | 9.66 x 1000 |
| Ask | 9.70 x 2200 |
| Day's Range | 9.42 - 10.00 |
| 52 Week Range | 5.34 - 47.86 |
| Volume | 188,498 |
| Avg. Volume | 563,310 |
| Market Cap | 140.382M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters' over-allotment option in full, bringing total follow-on public offering proceeds to $10.35 million.
- PR Newswire
Underwriters Exercise Over-Allotment Option in Full, Brings Total Follow-On Public Offering Proceeds to $10.35 Million
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced that the underwriters of the company's follow-on public offering exercised their over-allotment option in full, bringing total proceeds to $10.35 million.
- PR Newswire
Scopus BioPharma Announces Closing of $9 Million Follow-On Public Offering
Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. The company has granted the underwriters a 45-day option to purchase up to an additional 150,000 shares of common stock at the public offering price.
